首页 > 最新文献

Progress in medicinal chemistry最新文献

英文 中文
Glucokinase. Preface. 葡糖激酶。前言。
Q1 Pharmacology, Toxicology and Pharmaceutics
Progress in medicinal chemistry
Pub Date : 2013-01-01 DOI: 10.1016/B978-0-444-62652-3.10000-6
Geoff Lawton, David R Witty
{"title":"Glucokinase. Preface.","authors":"Geoff Lawton, David R Witty","doi":"10.1016/B978-0-444-62652-3.10000-6","DOIUrl":"https://doi.org/10.1016/B978-0-444-62652-3.10000-6","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"52 ","pages":"v-vii"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-444-62652-3.10000-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31217739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimalarial drug discovery: recent progress and future directions. 抗疟药物的发现:最新进展和未来方向。
Q1 Pharmacology, Toxicology and Pharmaceutics
Progress in medicinal chemistry
Pub Date : 2013-01-01 DOI: 10.1016/B978-0-444-62652-3.00003-X
Félix Calderón, David M Wilson, Francisco-Javier Gamo
{"title":"Antimalarial drug discovery: recent progress and future directions.","authors":"Félix Calderón, David M Wilson, Francisco-Javier Gamo","doi":"10.1016/B978-0-444-62652-3.00003-X","DOIUrl":"https://doi.org/10.1016/B978-0-444-62652-3.00003-X","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"52 ","pages":"97-151"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-444-62652-3.00003-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31217737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 31
Medicinal chemistry of glucagon-like peptide receptor agonists. 胰高血糖素样肽受体激动剂的药物化学。
Q1 Pharmacology, Toxicology and Pharmaceutics
Progress in medicinal chemistry
Pub Date : 2013-01-01 DOI: 10.1016/B978-0-444-62652-3.00002-8
Lyn H Jones, David A Price
{"title":"Medicinal chemistry of glucagon-like peptide receptor agonists.","authors":"Lyn H Jones, David A Price","doi":"10.1016/B978-0-444-62652-3.00002-8","DOIUrl":"https://doi.org/10.1016/B978-0-444-62652-3.00002-8","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"52 ","pages":"45-96"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-444-62652-3.00002-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31217736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Property-based design in the optimisation of benzamide glucokinase activators: from hit to clinic. 苯甲酰胺葡萄糖激酶活化剂优化中的基于性能的设计:从hit到临床。
Q1 Pharmacology, Toxicology and Pharmaceutics
Progress in medicinal chemistry
Pub Date : 2013-01-01 DOI: 10.1016/B978-0-444-62652-3.00001-6
Darren McKerrecher, Michael J Waring
{"title":"Property-based design in the optimisation of benzamide glucokinase activators: from hit to clinic.","authors":"Darren McKerrecher, Michael J Waring","doi":"10.1016/B978-0-444-62652-3.00001-6","DOIUrl":"https://doi.org/10.1016/B978-0-444-62652-3.00001-6","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"52 ","pages":"1-43"},"PeriodicalIF":0.0,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-444-62652-3.00001-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31217735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Hematopoietic prostaglandin D synthase inhibitors. 造血前列腺素D合成酶抑制剂。
Q1 Pharmacology, Toxicology and Pharmaceutics
Progress in medicinal chemistry
Pub Date : 2012-01-01 DOI: 10.1016/B978-0-12-396493-9.00004-2
Sukanthini Thurairatnam
{"title":"Hematopoietic prostaglandin D synthase inhibitors.","authors":"Sukanthini Thurairatnam","doi":"10.1016/B978-0-12-396493-9.00004-2","DOIUrl":"https://doi.org/10.1016/B978-0-12-396493-9.00004-2","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"51 ","pages":"97-133"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-12-396493-9.00004-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40171225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
TRPV1 antagonists: clinical setbacks and prospects for future development. TRPV1拮抗剂:临床挫折及未来发展前景
Q1 Pharmacology, Toxicology and Pharmaceutics
Progress in medicinal chemistry
Pub Date : 2012-01-01 DOI: 10.1016/B978-0-12-396493-9.00002-9
Michael E Kort, Philip R Kym
{"title":"TRPV1 antagonists: clinical setbacks and prospects for future development.","authors":"Michael E Kort, Philip R Kym","doi":"10.1016/B978-0-12-396493-9.00002-9","DOIUrl":"https://doi.org/10.1016/B978-0-12-396493-9.00002-9","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"51 ","pages":"57-70"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-12-396493-9.00002-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40171223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 57
Multivalent dual pharmacology muscarinic antagonist and β₂ agonist (MABA) molecules for the treatment of COPD. 多价双重药理毒蕈碱拮抗剂和β 2激动剂(MABA)分子治疗COPD。
Q1 Pharmacology, Toxicology and Pharmaceutics
Progress in medicinal chemistry
Pub Date : 2012-01-01 DOI: 10.1016/B978-0-12-396493-9.00003-0
Adam D Hughes, Alexander McNamara, Tod Steinfeld
{"title":"Multivalent dual pharmacology muscarinic antagonist and β₂ agonist (MABA) molecules for the treatment of COPD.","authors":"Adam D Hughes, Alexander McNamara, Tod Steinfeld","doi":"10.1016/B978-0-12-396493-9.00003-0","DOIUrl":"https://doi.org/10.1016/B978-0-12-396493-9.00003-0","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"51 ","pages":"71-95"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-12-396493-9.00003-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40171224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
Small molecule bromodomain inhibitors: extending the druggable genome. 小分子溴结构域抑制剂:扩展可药物基因组。
Q1 Pharmacology, Toxicology and Pharmaceutics
Progress in medicinal chemistry
Pub Date : 2012-01-01 DOI: 10.1016/B978-0-12-396493-9.00001-7
Chun-Wa Chung
{"title":"Small molecule bromodomain inhibitors: extending the druggable genome.","authors":"Chun-Wa Chung","doi":"10.1016/B978-0-12-396493-9.00001-7","DOIUrl":"https://doi.org/10.1016/B978-0-12-396493-9.00001-7","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"51 ","pages":"1-55"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-12-396493-9.00001-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40171222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 43
The large scale restructuring of pharmaceutical company research function. Preface. 医药企业研究职能的大规模重组。前言。
Q1 Pharmacology, Toxicology and Pharmaceutics
Progress in medicinal chemistry
Pub Date : 2012-01-01 DOI: 10.1016/B978-0-12-396493-9.00005-4
G Lawton, David R Witty
{"title":"The large scale restructuring of pharmaceutical company research function. Preface.","authors":"G Lawton, David R Witty","doi":"10.1016/B978-0-12-396493-9.00005-4","DOIUrl":"https://doi.org/10.1016/B978-0-12-396493-9.00005-4","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"51 ","pages":"v-vi"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-12-396493-9.00005-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40171226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Designing drugs to avoid toxicity. 设计药物以避免毒性。
Q1 Pharmacology, Toxicology and Pharmaceutics
Progress in medicinal chemistry
Pub Date : 2011-01-01 DOI: 10.1016/B978-0-12-381290-2.00001-X
Graham F Smith
{"title":"Designing drugs to avoid toxicity.","authors":"Graham F Smith","doi":"10.1016/B978-0-12-381290-2.00001-X","DOIUrl":"https://doi.org/10.1016/B978-0-12-381290-2.00001-X","url":null,"abstract":"","PeriodicalId":20755,"journal":{"name":"Progress in medicinal chemistry","volume":"50 ","pages":"1-47"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/B978-0-12-381290-2.00001-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29667943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 85
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Progress in medicinal chemistry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1